Justin Leong - 20 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Product Officer
Signature
/s/ Michael J. Rider, attorney-in-fact for Mr. Leong
Issuer symbol
RMD
Transactions as of
20 Nov 2025
Net transactions value
$0
Form type
4
Filing time
24 Nov 2025, 15:28:40 UTC
Previous filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leong Justin Chief Product Officer 9001 SPECTRUM CENTER BLVD, SAN DIEGO /s/ Michael J. Rider, attorney-in-fact for Mr. Leong 21 Nov 2025 0001825782

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ReMed Common Stock Award $0 +1,848 +6.8% $0.000000 29,028 20 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met.